Funding Opportunity in Huntington Disease Research
Brain Canada and Huntington Society of Canada are pleased to announce the launch of the 2026 Navigator Research Program
Huntington disease, is a genetic brain disorder with physical, mental, and emotional symptoms. Huntington disease is often described as having elements of Parkinson disease, ALS, Alzheimer disease, and schizophrenia, all at the same time. One in every 7,000 Canadians has Huntington disease and approximately one in every 5,500 is at risk for developing the disease.
The Navigator Research Program is designed to provide funding for Canadian scientific research of direct and immediate relevance to Huntington disease; to provide a platform for the future recruitment of outstanding investigators to Huntington disease research; to facilitate research collaboration nationally and internationally, and research which is relevant to other neurodegenerative disorders as well as Huntington Disease.
Click here to view the Request for Applications.
Deadline for Letter Of Intent : March 13, 2026 (5:00 PM ET)
Deadline for receipt of Full Applications: June 5, 2026 (3:00 PM ET)
Send Letters of Intent and applications to: research@huntingtonsociety.ca
Questions may be directed to: research@huntingtonsociety.ca